EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
In Vitro Diagnostic Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998
This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.
Last updated 26 April 2024. Database contains 4821 unique substances/entries.
Filter the list
|
215-215-7
|
1313-99-1
|
Carc. 1A; STOT RE 1; Skin Sens. 1 |
|||
|
208-933-7
|
547-67-1
|
Carc. 1A; STOT RE 1; Skin Sens. 1 |
|||
|
234-323-5
|
11099-02-8
|
Carc. 1A; STOT RE 1; Skin Sens. 1 |
|||
|
252-840-4
|
36026-88-7
|
Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
-
|
11132-10-8
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
239-125-2
|
15060-62-5
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
215-216-2
|
1314-05-2
|
Carc. 1A; STOT RE 1; Skin Sens. 1 |
|||
|
250-788-7
|
31748-25-1
|
Carc. 1A; STOT RE 1; Skin Sens. 1 |
|||
|
232-104-9
|
7786-81-4
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1 |
|||
|
234-349-7
|
11113-75-0
|
Carc. 1A; Muta. 2; STOT RE 1; Skin Sens. 1 |
|||
|
235-260-6
|
12142-88-0
|
Carc. 1A; STOT RE 1; Skin Sens. 1 |
|||
|
239-974-9
|
15852-21-8
|
Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
239-967-0
|
15851-52-2
|
Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
234-824-9
|
12035-38-0
|
Carc. 1A; STOT RE 1; Skin Sens. 1 |
|||
|
235-752-0
|
12653-76-8
|
Carc. 1A; STOT RE 1; Skin Sens. 1 |
|||
|
234-825-4
|
12035-39-1
|
Carc. 1A; STOT RE 1; Skin Sens. 1 |
|||
|
239-876-6
|
15780-33-3
|
Carc. 1A; STOT RE 1; Skin Sens. 1 |
|||
|
238-032-4
|
14177-51-6
|
Carc. 1A; STOT RE 1; Skin Sens. 1 |
|||
|
274-755-1
|
70692-93-2
|
Carc. 1A; STOT RE 1; Skin Sens. 1 |
|||
|
242-533-3
|
18721-51-2
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
287-468-1
|
85508-43-6
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
249-555-2
|
29317-63-3
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
287-469-7
|
85508-44-7
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
300-094-6
|
93920-10-6
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
300-093-0
|
93920-09-3
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
225-656-7
|
4995-91-9
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Skin Corr. 1A; Resp. Sens. 1; Skin Sens. 1 |
|||
|
237-138-8
|
13654-40-5
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
222-102-6
|
3349-08-4
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
233-263-7
|
10101-96-9
|
Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
244-578-4
|
21784-78-1
|
Carc. 1A; STOT RE 1; Skin Sens. 1 |
|||
|
218-744-1
|
2223-95-2
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
231-827-7
|
7757-95-1
|
Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
240-235-8
|
16083-14-0
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
231-111-4
|
7440-02-0
|
Carc. 2; STOT RE 1; Skin Sens. 1 |
|||
|
231-111-4
|
7440-02-0
|
Carc. 2; STOT RE 1; Skin Sens. 1 |
|||
|
200-193-3
|
54-11-5
|
Acute Tox. 2 |
|||
|
217-682-2
|
1929-82-4
|
Acute Tox. 4 |
|||
|
231-714-2
|
7697-37-2
|
Ox. Liq. 3; Acute Tox. 3; Skin Corr. 1A |
|||
|
238-076-4
|
14216-75-2
|
Ox. Sol. 2; Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
DABCO X-412
|
413-670-8
|
103969-79-5
|
Eye Irrit. 2; Skin Sens. 1 |
||
|
202-716-0
|
98-95-3
|
Carc. 2; Repr. 1B; Acute Tox. 3; STOT RE 1 |
yes |
||
|
201-188-9
|
79-24-3
|
Flam. Liq. 3; Acute Tox. 4 |
|||
|
217-406-0
|
1836-75-5
|
Carc. 1B; Repr. 1B; Acute Tox. 4 |
|||
|
233-272-6
|
10102-44-0
|
Press. Gas; Ox. Gas 1; Acute Tox. 2; Skin Corr. 1B |
|||
|
200-876-6
|
75-52-5
|
Flam. Liq. 3; Acute Tox. 4 |
|||
|
210-698-0
|
621-64-7
|
Carc. 1B; Acute Tox. 4 |
|||
|
-
|
60999-18-0
|
Acute Tox. 3; STOT RE 2 |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||